![Daniel Yadegar](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Daniel Yadegar
Direttore/Membro del Consiglio presso
LUMOS PHARMA, INC.
Profilo
Daniel Yadegar is the founder of Newpath Management LP, founded in 2018.
Dr. Yadegar currently holds the positions of Director at Lumos Pharma, Inc. and Managing Partner at Double Point Ventures LLC.
Dr. Yadegar completed undergraduate education at Harvard University in 1999 and graduate education at Weill Cornell Medical College in 2004.
Posizioni attive di Daniel Yadegar
| Società | Posizione | Inizio |
|---|---|---|
| LUMOS PHARMA, INC. | Direttore/Membro del Consiglio | - |
Newpath Management LP
 Newpath Management LP Investment ManagersFinance Newpath Partners invests in companies located in the United States. The firm targets companies operating in the fields of biotechnology and life sciences sectors. It provides financing for early stage capital requirements. | Fondatore | 01/09/2018 |
Formazione di Daniel Yadegar
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
100
+
Relazioni di 1° grado
4
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 4 |
|---|---|
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Weill Cornell Medical College
 Weill Cornell Medical College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Newpath Management LP
Newpath Management LP Investment ManagersFinance Newpath Partners invests in companies located in the United States. The firm targets companies operating in the fields of biotechnology and life sciences sectors. It provides financing for early stage capital requirements. | Finance |
Lumos Pharma, Inc.
 Lumos Pharma, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company that develops and markets therapeutics for rare diseases | Health Technology |
